The core therapeutic use of this botanical preparation aligns with the established applications of its key components, such as Valerian root. Sedatol is commonly used to help manage symptoms related to nervous tension and inner restlessness that may arise from everyday stress and temporary emotional strain.

Supportive Relief for Nervous Agitation

This preparation is used for managing symptoms related to mild nervous tension and inner restlessness. By contributing to a state of general calmness, it provides supportive relief that helps ease the overall symptom burden of agitation, helping patients cope more steadily during periods when symptoms intensify temporarily.

Easing Mild Sleep Initiation Difficulties

Sedatol is relevant when mild sleep initiation difficulties are linked to an overactive mind or the inability to relax. It is relevant in contexts of pre-sleep preparation to assist with natural relaxation, supporting the patient's ability to transition toward a tranquil state relevant for sleep initiation.

Management of Functional Somatic Tension

The formulation is applied to help address certain physical symptoms that are symptomatic manifestations of psychological tension. It provides supportive relief for functional complaints, such as mild nervous gastrointestinal gripes or functional heart discomfort, and generally contributes to improved comfort during symptomatic periods.

Quick Fact: Relief for Nervous Agitation

Regulatory References

1. European Medicines Agency (EMA) monograph on Valerian root

Official Eligibility and Contraindications

Sedatol's official eligibility profile is strictly defined by regulatory authorities based on contraindications and data sufficiency for specific patient groups. The medicine is contraindicated and must not be used by pregnant women. This absolute exclusion is based on the presence of one component, Passion Flower, which has documented uterine-stimulant properties. Use is also strictly prohibited for individuals with a known hypersensitivity or allergy to any of the product’s five active botanical components or excipients.

Official labeling establishes use only for the adult population (18 years and older). Use is not recommended for children and adolescents under 18 years because official data supporting safety and efficacy in this age group are currently considered insufficient. Furthermore, the product is not recommended for women who are breastfeeding as safety has not been established regarding excretion into human milk.

Eligibility is also limited by comorbidity-based restrictions. Patients with pre-existing liver problems (hepatic impairment) must consult a health professional before use, as regulatory warnings note a rare potential for liver effects. The medicine should also generally be avoided by patients with certain cardiac arrhythmias or other specific cardiac abnormalities.

Interactions with other medicines and products

Sedatol's official interaction profile, based on government regulatory documentation, highlights risks related to additive sedative effects and potential pharmacokinetic alterations due to its multi-component composition. The documented interactions define specific restrictions and cautions required for co-administration.

Documented Interaction Categories

Interaction Type	Interacting Products/Substances	Regulatory Statement
Pharmacodynamic (Additive Effects)	Central Nervous System (CNS) Depressants (e.g., benzodiazepines, barbiturates)	Caution advised due to the risk of reinforced sedative effects.
Pharmacodynamic (Consumption Restriction)	Alcohol (Ethanol)	Official documents state that alcohol should be avoided or restricted due to the confirmed risk of enhanced CNS depression.
Pharmacokinetic (Exposure Increase Risk)	CYP3A4 Substrates	Component-level data acknowledges the potential for enzyme inhibition, which may increase the plasma concentration of co-administered medicines.
Pharmacokinetic (Exposure Increase Risk)	P-glycoprotein (P-gp) Substrates	Component data notes the potential for transporter inhibition, which may lead to increased systemic exposure of substrate medicines.

Regulatory Summary

While there are no universally classified absolute contraindications listed in the label based solely on interaction risk, regulatory information requires specific cautions. No mandatory time separation rules are documented for co-administration, and no population-specific (e.g., elderly, hepatic) interaction notes are present in the official prescribing information.

The action of Sedatol is mediated through a multi-component formula that engages coordinated mechanisms across central and peripheral physiological systems. The mechanism is centered on three core domains:

Central Inhibition and Neural Stabilization

This domain encompasses the action of key ingredients (including Valerian and Passion Flower) that primarily target the GABA A receptor complex in the central nervous system. By acting as Positive Allosteric Modulators (PAMs), the components enhance the effect of the brain's natural inhibitory neurotransmitter, GABA. This interaction facilitates neuronal hyperpolarization and a physiological reduction of generalized CNS excitability.

Autonomic Tone and Functional Cardiovascular Modulation

This domain is driven by components like Crataegus, which affect peripheral physiological responses. The mechanism involves promoting Nitric Oxide ( NO) release in the endothelium and inhibiting Cyclic AMP Phosphodiesterase (PDE) in the myocardium, thereby contributing to the modulation of vascular tone and affecting the functional response of the cardiovascular system.

Peripheral Muscle Excitability

This final domain is responsible for influencing the excitability and contractility of smooth and skeletal muscle fibers, mediated by components such as Piscidia. This peripheral mechanism influences muscle contractility and reflex excitability through mechanisms that affect the physiological state of muscle tissue.

Sedatol is a multi-component phytomedicine preparation designed exclusively for oral administration, typically available as a standardized dry extract or solution. The administration protocol specifies distinct frequency patterns depending on the therapeutic goal, while adhering to a fixed dose range.

The standard single dose for an adult is equivalent to 400 to 600 mg of the standardized dry extract. For the relief of mild nervous tension, this dose may be administered up to three times daily. When used to assist with mild sleep initiation difficulties, a single dose is taken approximately half to one hour before bedtime. Across all uses, the total intake is restricted and must not exceed four single doses in a 24-hour period.

The official usage guidelines establish that Sedatol is not suitable for acute interventional treatment. Due to its gradual onset, the medication must be used as a sustained course of therapy, with continued daily administration over 2 to 4 weeks being the established duration to achieve the optimal effect. Furthermore, the preparation is not recommended for use in children under 12 years of age, as data supporting use in this population is lacking.

Research Evidence / Overview of Studies for Sedatol

The scientific understanding of Sedatol, a multi-component herbal preparation, is drawn from clinical evaluations of its key ingredients, such as Valerian and Passion Flower, as well as research into similar proprietary combination formulas. The evidence contributes to the understanding of symptom patterns by exploring how symptoms are measured in people experiencing nervous tension and sleep difficulties. Findings reflect the specific conditions under which they were conducted.

Evidence for Mild Nervous Tension and Restlessness

The research base for this clinical situation consists primarily of Randomized Controlled Trials (RCTs) and Systematic Reviews that investigated the individual active components and various combination formulas. These studies was applied in studies examining patient-reported experiences of inner tension and restlessness in populations of healthy adults under stress and individuals with mild anxiety-related complaints. Research examined how subjects reported changes in restlessness using standardized scales. The findings contribute to understanding symptom patterns. Reports from trials examining various multi-component products describe patterns observed in the studies where outcomes varied, and the overall consistency of these reports evidence quality varies across studies.

Evidence for Mild Sleep Initiation Difficulties

The evidence base for this indication is substantially informed by RCTs and Systematic Reviews that was evaluated in adults reporting minor, temporary difficulties initiating sleep. Researchers examined specific outcomes related to sleep initiation, including the time subjects took to fall asleep (sleep latency) and the subjective quality of sleep. Reports describe patterns observed in the studies where outcomes related to sleep initiation were assessed following continuous administration over several weeks, and in trials following a single dose.

Evidence for Functional Somatic Tension

The research base for the formula’s use in functional physical symptoms, such as nervous heart complaints, relies predominantly on Observational Studies and Pharmacological Investigations of components such as Crataegus. Research in this area contributes to understanding symptom patterns mainly through long-standing traditional use and the documented properties of the individual ingredients. However, comparative evidence is lacking from dedicated, high-quality controlled trials specifically targeting these functional somatic endpoints using the full multi-component formula.

Duration of Study and Long-Term Follow-up

The clinical trials typically involve follow-up durations were limited, often spanning a few weeks to one or two months. This means that there is limited information for long-term outcomes regarding the sustained effects or the maintenance of observed patterns over extended periods.

Key Studies & References European Union herbal monograph on Valeriana officinalis L., radix (Valerian root)

Common questions about Sedatol (FAQ)

Q: What is Sedatol used for?

A: Sedatol is a prescription medication indicated for the short-term management of specific types of insomnia in adults. It is part of a class of drugs that acts on the central nervous system to help promote sleep.

Q: How does Sedatol work?

A: Sedatol is understood to interact with certain neurotransmitters in the brain that are associated with the regulation of the sleep-wake cycle. This interaction is believed to contribute to its sedative effects, which may aid in the initiation of sleep.

Q: What are the potential side effects of Sedatol?

A: Like many medications, Sedatol is associated with potential side effects. The most commonly reported side effects observed in clinical studies include drowsiness, dizziness, and headache. Other less common effects may include dry mouth or nausea. Patients should discuss all potential side effects and concerns with a healthcare provider.

Q: Is Sedatol addictive, or can it lead to dependence?

A: Sedatol has the potential for dependence and abuse, particularly when used for long periods or at higher than prescribed amounts. The risk of dependence may increase with the duration of use. It is important to use this medication exactly as directed by a healthcare professional to mitigate this risk. Abruptly stopping the medication after extended use may lead to withdrawal symptoms.

Q: How long can I safely take Sedatol?

A: Sedatol is generally intended for short-term use. Clinical practice guidelines often recommend its use for a limited period, typically a few weeks. The appropriate duration of therapy depends on the individual's condition and should be determined through ongoing consultation with a healthcare provider.

Q: Can I drink alcohol while taking Sedatol?

A: It is generally advised to avoid or limit alcohol consumption while taking Sedatol. Alcohol can intensify the sedative effects of the medication, potentially leading to increased drowsiness, dizziness, and impaired coordination. Combining the two may increase the risk of serious side effects, including respiratory depression.

Q: What should I do if I miss a dose?

A: If you miss a dose, guidance suggests taking it only if you can still ensure a full 7 to 8 hours of sleep before you need to be active again. Do not double the dose to make up for the missed one. If there is not enough time remaining for a full night's sleep, it is generally recommended to skip the missed dose and resume the normal schedule the following night. Specific instructions for missed doses should be confirmed with your prescribing clinician.

Official Storage and Disposal Requirements

Sedatol must be stored strictly according to the conditions stated in the regulatory labeling to maintain the stability of its botanical components.

Requirement Type	Official Condition
Temperature	Store below 25, C or 30, C (ambient room temperature range).
Protection	Keep in the original container and protect from light and moisture.
Handling	Do not freeze and typically do not refrigerate.
Child Safety	Must be stored out of the sight and reach of children.

---

The product must not be used past the expiration date (EXP) stated on the package. If Sedatol is a liquid, the label may define a limited period of use after the container is first opened, after which the remaining portion must be discarded. To dispose of unused or expired medicine, users are generally instructed to consult a pharmacist or utilize an official drug take-back program. The product should not be thrown into wastewater or household trash unless specific instructions permit this.